Table of Contents 1 Varicella Attenuated Live Vaccine Market Overview 1.1 Product Overview and Scope of Varicella Attenuated Live Vaccine 1.2 Varicella Attenuated Live Vaccine Segment by Type 1.2.1 Global Varicella Attenuated Live Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Monovalent Vaccine 1.2.3 Combination Vaccine 1.3 Varicella Attenuated Live Vaccine Segment by Application 1.3.1 Varicella Attenuated Live Vaccine Sales Comparison by Application: 2020 VS 2026 1.3.2 Kids Injection 1.3.3 Adults Injection 1.4 Global Varicella Attenuated Live Vaccine Market Size Estimates and Forecasts 1.4.1 Global Varicella Attenuated Live Vaccine Revenue 2015-2026 1.4.2 Global Varicella Attenuated Live Vaccine Sales 2015-2026 1.4.3 Varicella Attenuated Live Vaccine Market Size by Region: 2020 Versus 2026 2 Global Varicella Attenuated Live Vaccine Market Competition by Manufacturers 2.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers (2015-2020) 2.3 Global Varicella Attenuated Live Vaccine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Varicella Attenuated Live Vaccine Market Competitive Situation and Trends 2.5.1 Varicella Attenuated Live Vaccine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Varicella Attenuated Live Vaccine Players (Opinion Leaders) 3 Varicella Attenuated Live Vaccine Retrospective Market Scenario by Region 3.1 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Varicella Attenuated Live Vaccine Market Facts & Figures by Country 3.3.1 North America Varicella Attenuated Live Vaccine Sales by Country 3.3.2 North America Varicella Attenuated Live Vaccine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Varicella Attenuated Live Vaccine Market Facts & Figures by Country 3.4.1 Europe Varicella Attenuated Live Vaccine Sales by Country 3.4.2 Europe Varicella Attenuated Live Vaccine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Varicella Attenuated Live Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Varicella Attenuated Live Vaccine Sales by Region 3.5.2 Asia Pacific Varicella Attenuated Live Vaccine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Varicella Attenuated Live Vaccine Market Facts & Figures by Country 3.6.1 Latin America Varicella Attenuated Live Vaccine Sales by Country 3.6.2 Latin America Varicella Attenuated Live Vaccine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Varicella Attenuated Live Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country 3.7.2 Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Varicella Attenuated Live Vaccine Historic Market Analysis by Type 4.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020) 4.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Type (2015-2020) 4.3 Global Varicella Attenuated Live Vaccine Price Market Share by Type (2015-2020) 4.4 Global Varicella Attenuated Live Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Varicella Attenuated Live Vaccine Historic Market Analysis by Application 5.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020) 5.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Application (2015-2020) 5.3 Global Varicella Attenuated Live Vaccine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Varicella Attenuated Live Vaccine Business 6.1 Merck 6.1.1 Corporation Information 6.1.2 Merck Description, Business Overview and Total Revenue 6.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merck Products Offered 6.1.5 Merck Recent Development 6.2 GSK 6.2.1 GSK Varicella Attenuated Live Vaccine Production Sites and Area Served 6.2.2 GSK Description, Business Overview and Total Revenue 6.2.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 GSK Products Offered 6.2.5 GSK Recent Development 6.3 BCHT 6.3.1 BCHT Varicella Attenuated Live Vaccine Production Sites and Area Served 6.3.2 BCHT Description, Business Overview and Total Revenue 6.3.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 BCHT Products Offered 6.3.5 BCHT Recent Development 6.4 Changsheng 6.4.1 Changsheng Varicella Attenuated Live Vaccine Production Sites and Area Served 6.4.2 Changsheng Description, Business Overview and Total Revenue 6.4.3 Changsheng Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Changsheng Products Offered 6.4.5 Changsheng Recent Development 6.5 Keygen 6.5.1 Keygen Varicella Attenuated Live Vaccine Production Sites and Area Served 6.5.2 Keygen Description, Business Overview and Total Revenue 6.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Keygen Products Offered 6.5.5 Keygen Recent Development 6.6 Green Cross 6.6.1 Green Cross Varicella Attenuated Live Vaccine Production Sites and Area Served 6.6.2 Green Cross Description, Business Overview and Total Revenue 6.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Green Cross Products Offered 6.6.5 Green Cross Recent Development 6.7 Biken 6.6.1 Biken Varicella Attenuated Live Vaccine Production Sites and Area Served 6.6.2 Biken Description, Business Overview and Total Revenue 6.6.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Biken Products Offered 6.7.5 Biken Recent Development 7 Varicella Attenuated Live Vaccine Manufacturing Cost Analysis 7.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine 7.4 Varicella Attenuated Live Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Varicella Attenuated Live Vaccine Distributors List 8.3 Varicella Attenuated Live Vaccine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Varicella Attenuated Live Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Type (2021-2026) 10.2 Varicella Attenuated Live Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Application (2021-2026) 10.3 Varicella Attenuated Live Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Region (2021-2026) 10.4 North America Varicella Attenuated Live Vaccine Estimates and Projections (2021-2026) 10.5 Europe Varicella Attenuated Live Vaccine Estimates and Projections (2021-2026) 10.6 Asia Pacific Varicella Attenuated Live Vaccine Estimates and Projections (2021-2026) 10.7 Latin America Varicella Attenuated Live Vaccine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Varicella Attenuated Live Vaccine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Varicella Attenuated Live Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Varicella Attenuated Live Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Varicella Attenuated Live Vaccine Manufacturers Covered in This Study Table 5. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Manufacturers (2015-2020) Table 6. Global Varicella Attenuated Live Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Varicella Attenuated Live Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Varicella Attenuated Live Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020) Table 10. Manufacturers Varicella Attenuated Live Vaccine Sales Sites and Area Served Table 11. Manufacturers Varicella Attenuated Live Vaccine Product Types Table 12. Global Varicella Attenuated Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Varicella Attenuated Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Attenuated Live Vaccine as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Varicella Attenuated Live Vaccine Players Table 16. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Region (2015-2020) Table 17. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Varicella Attenuated Live Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Varicella Attenuated Live Vaccine Sales by Country (2015-2020) (K Doses) Table 21. North America Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Varicella Attenuated Live Vaccine Sales by Country (2015-2020) (K Doses) Table 25. Europe Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Varicella Attenuated Live Vaccine Sales by Region (2015-2020) (K Doses) Table 29. Asia Pacific Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Varicella Attenuated Live Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Varicella Attenuated Live Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Varicella Attenuated Live Vaccine Sales by Country (2015-2020) (K Doses) Table 33. Latin America Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country (2015-2020) (K Doses) Table 37. Middle East and Africa Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020) Table 41. Global Varicella Attenuated Live Vaccine Sales Share by Type (2015-2020) Table 42. Global Varicella Attenuated Live Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2015-2020) Table 44. Global Varicella Attenuated Live Vaccine Price (USD/Dose) by Type (2015-2020) Table 45. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020) Table 46. Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2015-2020) Table 48. Merck Varicella Attenuated Live Vaccine Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 51. Merck Main Product Table 52. Merck Recent Development Table 53. GSK Varicella Attenuated Live Vaccine Corporation Information Table 54. GSK Corporation Information Table 55. GSK Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 56. GSK Main Product Table 57. GSK Recent Development Table 58. BCHT Varicella Attenuated Live Vaccine Corporation Information Table 59. BCHT Corporation Information Table 60. BCHT Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 61. BCHT Main Product Table 62. BCHT Recent Development Table 63. Changsheng Varicella Attenuated Live Vaccine Corporation Information Table 64. Changsheng Corporation Information Table 65. Changsheng Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 66. Changsheng Main Product Table 67. Changsheng Recent Development Table 68. Keygen Varicella Attenuated Live Vaccine Corporation Information Table 69. Keygen Corporation Information Table 70. Keygen Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 71. Keygen Main Product Table 72. Keygen Recent Development Table 73. Green Cross Varicella Attenuated Live Vaccine Corporation Information Table 74. Green Cross Corporation Information Table 75. Green Cross Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 76. Green Cross Main Product Table 77. Green Cross Recent Development Table 78. Biken Varicella Attenuated Live Vaccine Corporation Information Table 79. Biken Corporation Information Table 80. Biken Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 81. Biken Main Product Table 82. Biken Recent Development Table 83. Sales Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Varicella Attenuated Live Vaccine Distributors List Table 86. Varicella Attenuated Live Vaccine Customers List Table 87. Market Key Trends Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 89. Key Challenges Table 90. Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Type (2021-2026) Table 91. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Type (2021-2026) Table 92. Global Varicella Attenuated Live Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 93. Global Varicella Attenuated Live Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 94. Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Application (2021-2026) Table 95. Global Varicella Attenuated Live Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 96. Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Region (2021-2026) Table 97. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Region (2021-2026) Table 98. Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 99. Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Varicella Attenuated Live Vaccine Figure 2. Global Varicella Attenuated Live Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Monovalent Vaccine Product Picture Figure 4. Combination Vaccine Product Picture Figure 5. Global Varicella Attenuated Live Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 6. Kids Injection Figure 7. Adults Injection Figure 8. Global Varicella Attenuated Live Vaccine Market Size 2015-2026 (US$ Million) Figure 9. Global Varicella Attenuated Live Vaccine Sales Capacity (K Doses) (2015-2026) Figure 10. Global Varicella Attenuated Live Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Varicella Attenuated Live Vaccine Sales Share by Manufacturers in 2020 Figure 12. Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Varicella Attenuated Live Vaccine Revenue in 2019 Figure 14. Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020) Figure 16. Global Varicella Attenuated Live Vaccine Sales Market Share by Region in 2019 Figure 17. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2015-2020) Figure 18. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region in 2019 Figure 19. North America Varicella Attenuated Live Vaccine Sales Market Share by Country in 2019 Figure 20. North America Varicella Attenuated Live Vaccine Revenue Market Share by Country in 2019 Figure 21. U.S. Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 22. U.S. Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 24. Canada Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Varicella Attenuated Live Vaccine Sales Market Share by Country in 2019 Figure 26. Europe Varicella Attenuated Live Vaccine Revenue Market Share by Country in 2019 Figure 27. Germany Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 28. Germany Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 30. France Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 32. U.K. Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 34. Italy Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 36. Russia Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Varicella Attenuated Live Vaccine Sales Market Share by Region in 2019 Figure 38. Asia Pacific Varicella Attenuated Live Vaccine Revenue Market Share by Region in 2019 Figure 39. China Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 40. China Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 42. Japan Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 44. South Korea Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 46. India Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 48. Australia Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 50. Taiwan Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 52. Indonesia Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 54. Thailand Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 56. Malaysia Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 58. Philippines Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 60. Vietnam Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Varicella Attenuated Live Vaccine Sales Market Share by Country in 2019 Figure 62. Latin America Varicella Attenuated Live Vaccine Revenue Market Share by Country in 2019 Figure 63. Mexico Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 64. Mexico Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 66. Brazil Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 68. Argentina Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Varicella Attenuated Live Vaccine Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Varicella Attenuated Live Vaccine Revenue Market Share by Country in 2019 Figure 71. Turkey Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 72. Turkey Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 74. Saudi Arabia Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Varicella Attenuated Live Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 76. U.A.E Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Varicella Attenuated Live Vaccine by Type (2015-2020) Figure 78. Sales Market Share of Varicella Attenuated Live Vaccine by Type in 2019 Figure 79. Revenue Share of Varicella Attenuated Live Vaccine by Type (2015-2020) Figure 80. Revenue Market Share of Varicella Attenuated Live Vaccine by Type in 2019 Figure 81. Global Varicella Attenuated Live Vaccine Sales Growth by Type (2015-2020) (K Doses) Figure 82. Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020) Figure 83. Global Varicella Attenuated Live Vaccine Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Varicella Attenuated Live Vaccine by Application (2015-2020) Figure 85. Global Revenue Share of Varicella Attenuated Live Vaccine by Application in 2020 Figure 86. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. BCHT Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Changsheng Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Keygen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Green Cross Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Biken Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Price Trend of Key Raw Materials Figure 94. Manufacturing Cost Structure of Varicella Attenuated Live Vaccine Figure 95. Manufacturing Process Analysis of Varicella Attenuated Live Vaccine Figure 96. Varicella Attenuated Live Vaccine Industrial Chain Analysis Figure 97. Channels of Distribution Figure 98. Distributors Profiles Figure 99. Porter's Five Forces Analysis Figure 100. North America Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 101. North America Varicella Attenuated Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 102. Europe Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 103. Europe Varicella Attenuated Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Latin America Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 105. Latin America Varicella Attenuated Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Middle East and Africa Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa Varicella Attenuated Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Asia Pacific Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific Varicella Attenuated Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Merck GSK BCHT Changsheng Keygen Green Cross Biken